Indivior (INDV)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 363.70p Today's change: +1.45%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 363.70p 5 day change: +0.89%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 363.70p 6 month change: -10.88%

Contact details

Address: 103-105 Bath Road,Slough,Berkshire
Phone:
Fax:
Website: www.Indivior.com

Company information

FTSE 250 pharmaceuticals firm Indivior posted a drop in profits in the first quarter as it failed to fend off [...]

2 May 2018
Views
88

UK pharmaceuticals company Indivior gave investors a bitter pill to swallow this morning, as it announced a [...]

23 March 2018
Views
779

Shares in FTSE 250 drugmaker Indivior dropped today after the firm said it was forced to set more money aside [...]

15 February 2018
Views
143

GlaxoSmithKline (GSK) today announced it has launched a lawsuit against US-based Gilead Sciences over alleged [...]

8 February 2018
Views
290

FTSE 250 drugmaker Indivior has partnered with Swiss firm Addex Therapeutics to develop drugs to combat alcohol [...]

3 January 2018
Shares
1
Views
132

Drugmaker Indivior's shares got a fresh boost this morning after the US Food and Drug Administration (FDA) announced [...]

1 December 2017
Views
181

Shares in drugmaker Indivior jumped today after the company announced a US Food and Drug Administration (FDA) [...]

1 November 2017
Views
124

FTSE 250 drugmaker Indivior is gearing up to appeal a US court ruling that said a proposed generic version [...]

1 September 2017
Views
6

FTSE-250 drug company Indivior's full-year pre-tax profits have taken a beating from a $220m (£176m) litigation [...]

22 February 2017
Views
212

Shares at Indivior crumbled during yesterday’s trade but recovered to be down only 2.4 per cent.

12 February 2015
Views
199

Content tagged with "Indivior"